Richaud P, Hoerni-Simon G, Denepoux R, Durand M, Hoerni B, Lagarde C
Strahlentherapie. 1979 Nov;155(11):736-9.
The authors present the preliminary results of a new technique of total body irradiation (T.B.I.) used in 30 patients with hematological malignancy. The schedule proposed is easy to use and reproducible. The clinical and hematologic tolerance is good even for patients having had previous cyclic polychemotherapy and/or large-field irradiation. Low-grade non-Hodgkin lymphomas previously nontreated appear to be the best indication. Further investigations have to be performed particularly to specify the interest of combining T.B.I. and chemotherapy or T.B.I. and radiotherapy in the treatment of non-Hodgkin lymphomas.
作者介绍了一种用于30例血液系统恶性肿瘤患者的全身照射（T.B.I.）新技术的初步结果。所提出的方案易于使用且可重复。即使对于先前接受过周期性多药化疗和/或大野照射的患者，临床和血液学耐受性也良好。先前未治疗的低度非霍奇金淋巴瘤似乎是最佳适应证。尤其需要进一步开展研究，以明确在非霍奇金淋巴瘤的治疗中联合全身照射与化疗或全身照射与放疗的益处。
